seekingalpha

Author page description

November 1

October 31

October 30

October 29

  • Ares Capital's Q3: Important Implications For BDCs
    1. Ares Capital (ARCC) released its Q3 2025 results, highlighting implications for both the company and the broader BDC sector; 2. The article addresses recent negative sentiment toward private credit markets and analyzes whether concerns about the BDC sector are justified; 3. The author updates their investment outlook on ARCC stock and discloses existing positions in related BDCs like MSDL, GLAD, and KBDC.
    BDC SectorEarnings ReportInvestment Analysis
  • UnitedHealth: Strong Long-Term Fundamentals, But Risks Also Exist
    1. TSMC and Intel are competing for dominance in advanced semiconductor manufacturing, particularly in 2nm chip technology; 2. TSMC maintains technological leadership with superior R&D and production capabilities, while Intel seeks to catch up through U.S. government subsidies and strategic investments; 3. The rivalry reflects broader geopolitical tensions and impacts global tech supply chains, with implications for AI, quantum computing, and national security.
    TSMC vs IntelChip ManufacturingTechnology Leadership

October 28

  • Palantir: Q3 Could Ignite A Massive Bull Run (Double Upgrade)
    1. Palantir's strong momentum and bullish sentiment ahead of Q3 earnings are driving stock gains; 2. Major government defense deals in the UK and Poland, alongside commercial partnerships with Boeing and Snowflake, enhance revenue growth and AI leadership; 3. Technical indicators suggest a potential post-earnings breakout, justifying a short-term Buy rating despite high valuation risks.
    Earnings MomentumGovernment ContractsAI Partnerships
  • Gold Might Be The Winner This Earnings Season
    1. Gold emerges as a top performer this earnings season due to global de-dollarization and record gold reserve accumulation by central banks; 2. Central banks are reducing U.S. dollar holdings, with 43% planning to increase gold reserves amid concerns over U.S. debt and currency risks; 3. Major banks predict gold prices could surge to $5,000–$7,000 per ounce by 2026–2029, driven by geopolitical instability and declining trust in dollar assets, making gold a strategic hedge for investors.
    Gold InvestmentDe-dollarizationCentral Bank Reserves
  • With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big
    1. Eli Lilly acquired Adverum Biotechnologies to obtain Ixo-vec, a gene therapy targeting wet age-related macular degeneration (wAMD); 2. The low-risk deal, valued between $74.8M and $262M, offers significant growth potential if Ixo-vec succeeds as a single-injection treatment in the $9B global wAMD market; 3. Despite the strategic move, the author maintains a 'hold' rating on Eli Lilly due to valuation concerns and awaits further pipeline developments.
    AcquisitionGene TherapyMarket Potential

October 27

October 26

October 25

October 24